S&P 500 and Nasdaq 100 index futures continued their pre-market gains after the data was released.The institution is optimistic about these stocks today. On December 11th, as of press time, the institution gave 22 latest buy ratings, among which the target price of 8 stocks was announced:-Steady Medical was optimistic about Huatai Securities, giving a target price of 48.44 yuan; -Hongqi Chain was favored by CITIC Securities, with a target price of 6.80 yuan; -Contemporary Amperex Technology Co., Limited, Jinshiyuan, Fulongma and many other stocks are listed.Analysts commented on the US CPI in November: It is still a consensus that the Fed will cut interest rates by 25 basis points again. JOSH HIRT, a senior American economist at VANGUARD, said: "The US CPI data in November confirmed the market consensus that the Fed will cut interest rates by 25 basis points again. We are still paying close attention to the strength of the labor market and the potential inflationary stickiness of some components of inflation (housing and services) before 2025. "
Wedbush raised the target price of C3.ai to $45, and Wedbush: raised the target price of C3.ai from $30 to $45, maintaining the "outperform" rating.Broadcom US stocks rose 3.6% before the market, while Apple US stocks rose 0.3% before the market. In the news, Apple is cooperating with Broadcom around artificial intelligence (AI) chips.Shuang Jie Electric: The controlling shareholder, actual controller and their concerted actions terminated the agreement to transfer part of the company's shares. Shuang Jie Electric announced that the controlling shareholder, actual controller Zhao Zhihong and their concerted actions Zhao Zhixing and Zhao Zhihao reached an agreement with Hangzhou Yingxin Enterprise Management Partnership (Limited Partnership) on the termination of the agreement to transfer part of the company's shares, and signed the Agreement on the Dissolution of the Share Transfer Agreement. According to the information previously disclosed, Zhao Zhihong, Zhao Zhixing and Zhao Zhihao intend to transfer 54 million shares of the company's unrestricted shares to Hangzhou Yingxin by agreement transfer, accounting for 6.76% of the company's total share capital. Due to the change of objective conditions, both parties decided to terminate the transfer of this share agreement, and they will not be liable for breach of contract.
The institution is optimistic about these stocks today. On December 11th, as of press time, the institution gave 22 latest buy ratings, among which the target price of 8 stocks was announced:-Steady Medical was optimistic about Huatai Securities, giving a target price of 48.44 yuan; -Hongqi Chain was favored by CITIC Securities, with a target price of 6.80 yuan; -Contemporary Amperex Technology Co., Limited, Jinshiyuan, Fulongma and many other stocks are listed.Layoff nearly 40%? Extremely more rumors: false statements, extremely more recently, some negative information has been sent out. Some netizens posted on social media that the more layoffs are started, the scale is close to 40%. In this regard, the reporter asked the extreme Vietnamese side for verification, and the other party said that the above rumors were false statements. In addition, the Automobile Legal Department of Extreme Vietnam also issued a document through Weibo, saying that some people spread false statements about the management and operation of Extreme Vietnam on the Internet, and the rumors have had a bad influence on the normal operation of the company. At present, the company is operating as usual, and relevant information is released through official channels. As for the rumors spread on the Internet, the company has retained evidence, reflected and reported them to the competent authorities, and has taken necessary legal measures to further investigate the legal responsibility of the rumors. Please don't believe in rumors, don't spread rumors. (per meridian)Lilly will study whether diet pills can effectively control addictive behaviors. Dave Ricks, CEO of Lilly, said that the company will start to study whether its best-selling diet pills can also effectively control addictive behaviors such as alcoholism, smoking and drug abuse. Ricks said at a meeting that these drugs are "anti-hedonic" and may temporarily make patients get rid of drug dependence. Some doctors have said that this drug can help alleviate drug addiction. Novo Nordisk also said earlier this year that it planned to conduct research on drug addiction.
Strategy guide
12-14
Strategy guide
12-14